Drug profile · INN
lypressin
DIAPID
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lypressin (DIAPID) is an FDA-listed pharmaceutical active ingredient. Route of administration: nasal. Current US regulatory status: approved.
Key facts
INN lypressin
Brand DIAPID
Route NASAL
Formulation SOLUTION
Frequently asked questions
What is lypressin?
lypressin (DIAPID) is an FDA-listed pharmaceutical active ingredient. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for lypressin?
DIAPID is a marketed brand name for lypressin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lypressin?
lypressin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.